420 with CNW — Predictions, Trends for Cannabis Industry This Year

As the first month of 2023 drew to a close amid price compression, chronic oversupply and a possible recession, several marijuana industry professionals offered their predictions on how the industry will perform for the rest of the year. The trends of oversupply and price compression will most likely continue through the year, experts believe, with market oversaturation and oversupply reducing access to capital and causing prices to drop.

Arizona Dispensaries Association’s president of the board Lilach Mazor Power stated that players in the cannabis industry would have to make tough business decisions due to oversupply. Businesses will have to find unique and innovative ways to differentiate themselves from competitors, compete with the black market and attract more customers to their brands.

Consolidation within the industry is also expected to continue but at a reduced rate. The past couple of years have been characterized by several mergers and acquisitions in the cannabis industry. However, some experts believe that consolidation may slow down this year because of limited access to capital. Masha Ty from ACS Laboratory says that while consolidation points to industry maturation, it can also eradicate craft brands that simply can’t compete due to lower cannabis flower prices and complex regulations.

Another prediction for 2023 is increased on-site cannabis consumption for customers. Most, if not all, states with legal cannabis markets have banned public consumption. This means that tourists who travel to states with recreational markets usually have no way to consume legal cannabis unless a resident invites them into their home.

Smoke Honest cofounder Mason Palmer said that cannabis consumption lounges will “change the game” by encouraging safe and thoughtful consumption through “thoughtful design, art and experiential spaces.” More mature markets will also be able to improve the customer experience by making it possible for customers to test the product onsite before buying it, Palmer said.

This year will also see an influx of cannabis events, Visit Holyweed editor Dan Wilson said, with California especially seeing an increase in cannabis-related events and happenings. We can also expect the entry of more cannabinoids in the market,  High Road Edibles chief operating officer Mike Zens said. Zens predicts that CBGCBN and CBD-infused products will see growing popularity among customers throughout the year, challenging the industry’s reliance on THC potency.

Fruit Slabs chief operating officer Brandon Dorsky also predicts that 2023 will be the year for infused pre-rolls and beverages, a prediction that is shared by Grove Bags Chief Marketing Officer Lance Lambert. Lambert believes that cannabis-infused beverages, edibles and elixirs will come into their own in 2023, especially as younger generations increasingly turn away from alcohol to other social drugs that have little to no side effects.

And even though there is little chance lawmakers will legalize cannabis at the federal level, we can expect more states to pass marijuana legalization measures. At the moment, states such as Hawaii, Ohio, Minnesota, Oklahoma and Pennsylvania have a good shot at legalizing cannabis use for adults this year.

If those states pass legalization measures, financing alternatives such as those provided by REZYFi Inc. could grow in importance to support the growth of the industry in those newly created markets.

NOTE TO INVESTORS: The latest news and updates relating to REZYFi Inc. are available in the company’s newsroom at https://cnw.fm/REZY

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — State Data Shows Massachusetts Adult-Use Cannabis Sales Have Reached $4B

Authorities in Massachusetts have reported that adult-use cannabis sales in the state have officially exceeded $4 billion since legalization in 2018. Cannabis Control Commission data shows that the state’s gross marijuana sales stood at $4,000,732,607 as of Jan. 12, 2023. This comes a few months after the state reached the $3 billion milestone, indicating continued industry growth.

Currently, Massachusetts has 14 delivery services and 265 retailers. Authorities track and share sales data via the CCC’s Open Data portal. Last year, the state reported$1,483,898,511 worth of cannabis sales.

Separate data from that portal indicates that medical cannabis sales, which are currently valued at $975.4 million, are expected to hit $1 billion between November 2018 and January 2023. While recreational cannabis sales began more recently than medical cannabis sales, regulators track both programs on the platform.

Since the state became the first one on the East Coast to open adult-use stores, the demand from consumers for tested, high-quality cannabis products has remained strong, according to CCC executive director Shawn Collin.

The regulators reaffirmed their dedication to advancing equity around the industry by noting the existence of 29 SEP license holders, 17 Economic Empowerment license holders, and 50 state-certified minority businesses, including women and veterans.

The CCC is also gearing up to start the Social Equity Program‘s fourth cohort this year. The cohort is a free statewide program that offers assistance and training to those who have been indirectly hurt by cannabis enforcement and prohibition and want to work in the legal marijuana industry. The commission claims that the program has benefited close to 900 participants so far. The data also revealed that, for the first time, cannabis sales outpaced alcohol sales in terms of tax revenue for the state last year.

In the meantime, recent state data shows that Michigan marijuana sales reached an all-time high in December. Despite the gradual decline in medical cannabis purchases, the recreational cannabis market has more than made up for it, with total sales reaching $221.7 million by the end of last year.

Similar patterns have been observed in Arizona’s cannabis market, where authorities recently reported that marijuana sales hit an all-time high in October. While purchases of medical cannabis are declining in the state, the adult-use market is growing.

In Illinois, cannabis sales reached an all-time high of more than $1.5 billion last year, with December of last year marking the highest monthly sales volume to date.

These impressive sales records, in a way, suggest that ancillary companies such as Advanced Container Technologies Inc. (OTC: ACTX), which don’t directly touch the marijuana plant, are also benefiting from the success of the industry.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — New Poll Finds Americans Favor Looser Cannabis Regulation, Tighter Regulation of EVs and Cryptos

A recent poll from Harvard CAPS-Harris has found that Americans favor looser regulations for marijuana and tighter rules for social media, cryptocurrencies, coal and electric vehicles. The survey polled voters on a broad range of national issues and asked them if they thought the government should regulate the issues more or less, or keep current regulations as they are.

Results indicate 45% of the survey participants stated that cannabis should be regulated looser than it is now, 22% said that cannabis regulations should stay as they are, and 33% wanted tighter cannabis regulations. Compared to all the other items in the poll, participants were more likely to say that cannabis needs fewer regulations.

An increasing number of states have moved to legalize cannabis for medical or recreational use over the past two decades, resulting in a massive industry that generates billions of dollars in sales and taxes.

Past surveys have found that a large portion of the American population is in favor of legalizing cannabis, and the success of consecutive reform efforts has more than proved their support. For instance, a recent poll from Data for Progress revealed that a majority of Democrat, Republican and Independent voters support the federal legalization of cannabis.

The Data for Progress study found that 75% of Democrats, 52% of Republicans and 67% of Independents believed that it was time for marijuana prohibition to end. Overall, 65% of American voters said that they supported legalizing cannabis at the federal level.

Pew Research Center poll released last November found that 10% of Americans believe cannabis should be totally illegal. The poll also indicated that  89% of U.S. adults said that marijuana should be legal for medical or recreational reasons with 45% of Republicans and 73% of Democrats supporting total legalization of cannabis.

The Harvard CAPS-Harris survey adds to the growing body of data showing that an increasing percentage of the American population simply doesn’t believe in prohibition.

With dozens of states now allowing either medical or recreational cannabis, millions of Americans have access to a legal cannabis market. The plant has proven to be extremely popular among consumers, allowing retailers across the country to sell cannabis products worth billions of dollars and hire hundreds of thousands of workers.

Several lawmakers, including Senate Majority Leader Chuck Schumer, are working on legislation to legalize cannabis at the federal level and grant cannabis businesses access to banking services and federal financial aid.

Additionally, the FDA recently released its finalized guidance on the development of cannabis-based drugs.

With companies such as India Globalization Capital Inc. (NYSE American: IGC) engaged in developing drugs from THC and other cannabis compounds, the FDA guidance couldn’t have come sooner.

NOTE TO INVESTORS: The latest news and updates relating to India Globalization Capital Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Shown to Elevate Drug Delivery Across Blood-Brain Barrier by ~1,900%

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, has developed its patented DehydraTECH(TM) technology, which is designed for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients. “DehydraTECH increases effectiveness and improves how these ingredients enter the bloodstream. Benefits of DehydraTECH include: improved speed of onset, with effects felt in minutes; increased bioavailability, with more of the drug delivered into the bloodstream; increased brain absorption, with testing suggesting up to 10x improvement; and improved drug potency, with more of the ingested product made available in the bloodstream requiring lower dosages,” a recent article reads. “Animal studies conducted by Lexaria have demonstrated a propensity for DehydraTECH technology to elevate the quantity of drug delivered across the blood-brain barrier by as much as 1,900%, which has initiated new patent applications and has opened the possibility of improved drug delivery.”

To view the full article, visit https://cnw.fm/ptmfg

About Lexaria Bioscience Corp.

Lexaria’s patented drug delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids, antiviral drugs, PDE5 inhibitors and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 28 patents granted and roughly 50 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Advanced Container Technologies Inc. (ACTX) Unveils New Line of GrowPod Controlled Environment Farms

Advanced Container Technologies (OTC: ACTX), the exclusive U.S. distributor of self-contained, automated, indoor “micro-farms” called GrowPods, has announced a new line of automated modular GrowPod systems. The new line is designed to expand the GrowPod offerings to a wider range of customers and specialty plant cultivations. The new systems, which are designed and built by GP Solutions, are also known as vertical farms, grow rooms and container farms; each option creates a clean environment that allow plants can grow to their full potential. The new offerings include Flex Farm, a five-tier, five-channel growing system with a hand sink, nursery, and prep area; Hydro Farm, a five-tier hydroponic growing system with many of the same features as the Flex Farm but without the hand sink, nursery and prep area; Hybrid Farm, a unique system with a five-tier, three-channel growing system on one side and a three-tier flood table on the other side; Grow Max, a soil-based pod that comes in single, dual and triple-tier setups designed to use less water while maximizing yields; Entry Unit, a clean room that can be configured for processing, fertigation, or multiple other uses; and DP1 Drying Unit that features NSF-rated insulated walls, dehumidification, circulation fans, HVAC system and carbon filtration that provides an ideal environment for drying plants. The announcement notes that the new line of pods is modular and stackable, making the pods ideal for an array of users, including farms, large commercial enterprises, nurseries, restaurants, grocery stores, nonprofits and more.  

To view the full press release, visit https://cnw.fm/1PT0n

About Advanced Container Technologies Inc.

Advanced Container Technologies is in the business of selling and distributing self-contained, automated, indoor “micro-farms” called GrowPods, along with related equipment and supplies. Additionally, the company designs and sells patented proprietary medical-grade plastic containers, known as the Medtainer(R), that store and grind pharmaceuticals, herbs, teas and other solids or liquids. For more information, visit the company’s website at www.AdvancedContainerTechnologies.com.

NOTE TO INVESTORS: The latest news and updates relating to ACTX are available in the company’s newsroom at https://cnw.fm/ACTX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Oklahoma Voters to Decide on Cannabis Legalization in March

The past two decades have seen a plethora of states across the country vote on measures to legalize either the medical or recreational use of marijuana. By the end of 2022, dozens of states allowed medical marijuana within their borders while nearly 20 states had legal recreational cannabis markets.

These state-level cannabis markets have been extremely lucrative for their home states, generating billions of dollars in cannabis taxes and creating hundreds of thousands of new job opportunities.

Voters in Oklahoma may soon be able to see some of this cannabis action after a measure to legalize cannabis was slated to be voted on in the upcoming March ballot. The initiative in question, State Question 820, would allow the possession and consumption of cannabis for individuals aged 21 years and older.

The campaign behind the cannabis initiative was led by Oklahomans for Sensible Marijuana Laws, with the aim of putting the initiative onto last year’s ballot. This did not happen, however, due to some legal challenges and the measure’s failure to meet the signature deadlines.

It did find new reprieve when Governor Kevin Stitt announced in October that Oklahomans would get to vote on the measure in March 2023. If the measure passes, it would allow persons to possess, distribute and transport up to one ounce of cannabis flower, eight grams of marijuana concentrate and eight grams of concentrated marijuana in a cannabis-infused product. Additionally, the measure would legalize home cultivation and allow residents in the state possess up to six seedlings and six mature cannabis plants.

The initiative would also afford individuals with certain cannabis-related convictions or sentences on their records an avenue to seek expungement or modify their records. Cannabis sales in Oklahoma would be subject to a 15% tax if the state launches a legal market for marijuana.

Oklahomans for Sensible Marijuana Laws worked hard to push the measure, raising $2.74 million through September 30, 2022, and spending $2.57 million on the campaign.

Oklahoma isn’t the only state looking to legalize adult-use cannabis in the upcoming ballots. In Ohio, reformists submitted 135,729 valid signatures for a cannabis legalization initiative before their proposal was forwarded to the Ohio General Assembly for approval.

If legislators take no action or choose to reject the initiative, the Coalition to Regulate Marijuana like Alcohol will have 90 days to submit an additional 124,046 signatures.

Ohio voters will be able to vote on the measure to legalize cannabis on the November ballot if the signature drive is successful.

For those who want to grow their own cannabis once this measure passes and is implemented, lots of indoor cultivation equipment makers, including Advanced Container Technologies Inc. (OTC: ACTX), could be on hand to avail supplies to ensure they succeed in their efforts.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Why Cannabis Firms Should Look Elsewhere for Financing

Currently, cannabis is legal in 21 states for recreational usage and 39 states for medical use, with total revenues anticipated to exceed $38.8 billion through 2023. The next logical stage in the development of the cannabis market is federal financial regulation for complying enterprises.

Theoretically, most other sectors’ opportunities for credit cards, deposits and loans should be available to the marijuana business as well. However, there hasn’t been a legislative majority or the political desire to make tax and banking reform regarding cannabis business to happen, despite numerous efforts in Congress to do so.

Despite numerous attempts, the usual bills from opposing parties in the U.S. Congress and Senate — MORECAOA and SAFE — have not been successfully passed. Furthermore, the outcomes of the latest elections do not indicate any quick progress.

So what can a diligent, compliant cannabis startup do to obtain the funding it requires to launch, maintain and grow its enterprise? The apparent solution is to raise more equity, but the process is challenging and often reduces the shareholdings of the entrepreneurs and executives.

For a clearance sale as well as other finance, should you opt for the REITs, which are flooded with inexpensive cash from the open market? Many prospective borrowers think specialty lending is horrendously overpriced; however, this viewpoint is founded on an incorrect understanding of the situation.

Even if federal financial reform is implemented, marijuana financing is expensive for all individuals who borrow for the business because a new industry’s inherent risk is constantly factored into borrowing rates. The region’s procedural and tax systems also make the marijuana industry compositionally ineffective and highly complicated, leading to increased costs for everything, along with money, which may persist regardless of the government initiatives that are put into place because tax revenues are the driving force behind legalization.

Specialty finance firms typically borrow money on a differential basis from other parties. As a result, if the Reserve Bank raises the rate of interest, the expense to the creditor increases, and borrowing costs follow. That is how capitalism operates.

The assumption is that the anticipated rise in income or drop in expenses will more than outweigh the capital expenditures.

Since time equates to money, your rivals are either extending their growing sites, introducing a gummy plant to their producing factory, or creating an additional retail outlet while you are awaiting the offer on your subsequent funding.

Therefore, national financial reform may eventually lead to a lower cost of borrowing, but you shouldn’t count on it in the short-term. Entities such as REZYFi Inc. are working to bridge the financing gap for marijuana industry players. More actors of this nature could eventually help the industry thrive despite lacking access to mainstream banks.

NOTE TO INVESTORS: The latest news and updates relating to REZYFi, Inc. are available in the company’s newsroom at https://cnw.fm/REZY

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – REZYFi Inc. Ideally Positioned as USDA Pushes Hemp Conversation Forward

REZYFi, a growth mortgage origination and specialized financing company that targets licensed and permitted cannabis companies, owners of real estate who lease to cannabis companies and companies and individual homeowners, is set to benefit from the growing support for the cannabis industry. “The United States Department of Agriculture (‘USDA’) is set to include hemp data in its 2022 Census of Agriculture. It is noted that with this inclusion, the organization is pushing the conversation around hemp and marijuana forward. It also signals the eventual integration and support of the overall cannabis industry. With this support, various companies within the sector are set to benefit, REZYFi being one of them,” a recent article reads. “REZYFi is banking on the federal legalization of this product. Its management is optimistic that this recent move by the USDA to include hemp data is a step in the right direction. More importantly, the company understands that this inclusion gives farmers a voice in the matter and the power to influence policy in a way that would favor the industry’s growth… The increasing support of the cannabis industry is proving more promising while presenting many growth opportunities for companies such as REZYFi.”

To view the full article, visit https://cnw.fm/8BpY3

About REZYFi Inc.

REZYFi is a cannabis-focused mortgage origination and specialized financing company in the U.S. The company originates, structures and invests in first mortgage loans and alternative structured financings secured by commercial and residential real estate properties. For more information, visit the company’s website at REZYFi.com.

NOTE TO INVESTORS: The latest news and updates relating to REZYFi are available in the company’s newsroom at https://cnw.fm/REZY

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — FDA Publishes Final Guidance for Cannabis Drug Development

Earlier this week, the FDA published its final guidance on cannabis drug development in the federal register. This comes after it released a draft version in 2020. The guidance outlines the basic clinical study standards, considerations for researchers and the drug development process.

The legalization of hemp in the 2018 Farm Bill is one major reason for the guidance’s release because it made the drug development process for hemp different from marijuana, which is still classified as a Schedule I substance under the Controlled Substances Act. In its statement, the agency said that the guidance outlined its views on topics related with the development of cannabis and cannabis-derived drugs for humans.

The FDA also made a number of nonbinding recommendations for scientists interested in the development of cannabis drugs that could be commercialized. The advice, the agency noted, was centered on addressing the regulatory controls and legal definitions related to cannabis as well as specific questions raised about drugs that contained cannabis.

One section of the guidance centers on how hemp can be distinguished from marijuana by calculating THC content. Legally, hemp is defined as cannabis that contains not more than 0.3% THC by dry weight.

In its final guidance, the FDA advises that researchers determine THC content in their proposed cannabis investigational drug products in the early stages of the development process. The agency notes that this may be useful because any drug products that contain more than 0.3% THC may be considered Schedule I substances.

Meanwhile, legislators and advocates await the FDA’s actions on permitting the marketing of hemp-based products such as CBD oil. Earlier in November, the agency sent warning letters to five companies that sold beverages and food containing CBD. While it did not specify why those particular companies were targeted, the agency did state that the companies sold products that individuals could confuse for traditional beverages or foods, resulting in overconsumption or unintentional consumption of CBD.

CBD (cannabidiol) is an active ingredient derived from the hemp plant. This compound is said to be beneficial for various health issues and, unlike THC, it does not induce any highs when ingested. A continued lack of clear regulations for CBD leaves stakeholders in the grey area and many more frustrated over the FDA’s slow rulemaking process.

In other news, the FDA has been tasked with carrying out a scientific review on marijuana to aid in the evaluation of its federal scheduling, as directed by President Joseph Biden.

For entities that are already conducting cannabis drug development, such as India Globalization Capital Inc. (NYSE American: IGC), the new guidance may simply clarify what they are already doing because any clinical development program can only take place once the needed approvals are granted by regulators, such as the DEA and the FDA.

NOTE TO INVESTORS: The latest news and updates relating to India Globalization Capital Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Study Shows Cannabis Boosts Sex Quality for All Genders

In a recent study, participants reported that cannabis increased their desire, intensified their orgasms, and sharpened their sensory perception, providing evidence that cannabis can improve sex. Moser Amanda, a sexologist residing in Denver who has specialized in integrating cannabis and sex, took part as the paper’s lead author.

More than 70% of respondents to Moser’s online questionnaire, which included more than 811 marijuana-using individuals, reported that smoking marijuana before sex enhanced orgasms and boosted desire, regardless of gender or age. The results showed greater sexual satisfaction and functioning. About 62.5% of users claimed that marijuana increased pleasure during masturbation.

According to the authors, the survey’s findings are important for ladies’ satisfaction. Recent research found that women who engage in sex with men are usually less likely to feel sexually satisfied than their partners. The study reports that women are likely to orgasm more frequently when using marijuana prior to sexual activities.

Moser used social media platforms and organizations that advocate for the decriminalization of marijuana and medical cannabis to draw participants. Only adults above the age of consent were eligible to respond.

The authors point out that a number of the results were consistent with earlier studies. For instance, higher desire and orgasmic intensity were reported by both men and women. Women asserted that they might have more orgasms more frequently.

Moser states that when participants used cannabis consciously prior to sex, sexual satisfaction increased by a large margin. Ladies who experience vaginismus and have lowered desire may profit from the ability of cannabis to relax muscles and improve sexual performance.

A 2019 survey with related findings was conducted by a researcher named Becky Lynn, a specialist in women’s reproductive health and university lecturer of gynecology and obstetrics at Maryland’s Saint Louis University. In that survey, women who admitted to using cannabis prior to sex were more likely to say they had more satisfying and intense orgasms.

However, based on another study, better sex does not necessarily result from consuming more cannabis. A literature review from 2019 found that marijuana affects arousal depending on the dosage, with lower levels of THC associated with more stimulation and pleasure. While most research has shown that cannabis may benefit female sexual function, the study found that too much THC can have a contrary effect.

Additionally, cannabis and sex have been positively linked in various online studies. Also, one survey revealed a possible link between the decriminalization of cannabis and enhanced sexual interactions.

As more enterprises such as REZYFi Inc. step up to provide alternative financing to marijuana industry actors in the absence of access to traditional banks, more innovative products could be introduced on the market so that other benefits of this plant can be brought to the fore.

NOTE TO INVESTORS: The latest news and updates relating to REZYFi, Inc. are available in the company’s newsroom at https://cnw.fm/REZY

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.